Intellectual Property Magazine
Combatting Covid-19
After a proposal to waive certain IP rights for Covid-19 vaccines was rejected by the TRIPS Council, Ben Wodecki speaks with Oxfam’s Anna Marriott and Kirkland & Ellis’ Daniel Lim on just how realistic the proposal was
Ben Wodecki
A proposal to waive certain IP rights in order to potentially ease access to Covid-19 vaccines was shot down
1 by Trade-Related Aspects of Intellectual Property Rights (TRIPS) council members in October, with the plan described as “an
extreme measure to address an unproven problem”.